Login

Company Executives

$ Management Team

Mr. Kenneth Bate

Independent Chairman of the Board

Age 74
Compensation $177.5K USD
Sex Male

Dr. Jill Milne

President

Chief Executive Officer

Co-Founder

Director

Age 57
Compensation $6.604M USD
Sex Female

Mr. Noah Clauser

Chief Financial Officer

Age 52
Compensation $1.355M USD
Sex Male

Mr. Benjamin Harshbarger

Chief Legal Officer

Age 56
Compensation $2.448M USD
Sex Male

Mr. Andrew Komjathy

Chief Commercial Officer

Age 62
Compensation -
Sex Male

Ms. Andrea Matthews

Chief Business Officer

Age 43
Compensation -
Sex Female

Mr. Christopher Morabito

Chief Medical Officer

Age 55
Compensation $2.481M USD
Sex Male

Ms. Elizabeth Higgins

Investor Relations

Age -
Compensation -
Sex Female
Directors
9
serving now
Independent
0 of 1
stated in the proxy; 8 not stated
Average tenure
7.1 years
from year joined
CEO also chairs the board
No
Kenneth Bate
Director Age On board Independent Committees Other public boards 2024 pay Source
Fred Callori
57 2021
4 years
Not stated
compensation nominating and corporate governance
None stated $135,980
Michael Kishbauch
76 2016
9 years
Not stated
compensation · Chair nominating and corporate governance
None stated $140,980
Jill C. Milne
57 2008
17 years
Not independent None stated None stated Paid as CEO
Kenneth Bate
74 2014
11 years
Not stated
audit nominating and corporate governance · Chair
Madrigal Pharmaceuticals, Inc. $177,480
Joanne Beck
64 2019
6 years
Not stated
compensation science and technology
None stated $139,480
Hugh Cole
60 2019
6 years
Not stated
audit
None stated $135,730
Sunil Agarwal
55 2024
1 year
Not stated
science and technology
Arvinas, Inc. $256,282
Gregg Lapointe
66 2019
6 years
Not stated
audit · Chair
None stated $146,980
Jonathan Violin
49 2021
4 years
Not stated
science and technology · Chair
None stated $141,980

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

7 disclosed in the proxy filed Apr 28, 2025
Perceptive Advisors, LLC
a beneficial owner of more than 5% or our voting securities at that time
$30.0 million
2024

Affiliates purchased 2,481,350 shares of common stock in the February 2024 underwritten offering at the public offering price

TCG Crossover Fund II, L.P.
a beneficial owner of more than 5% or our voting securities at that time
$11.0 million
2024

Affiliates purchased 910,000 shares of common stock in the February 2024 underwritten offering at the public offering price

Venrock Healthcare Capital Partners III, L.P.
a beneficial owner of more than 5% of our voting securities at that time
$11.0 million
2024

Affiliates purchased 910,000 shares of common stock in the February 2024 underwritten offering at the public offering price

RA Capital
a beneficial owner of more than 5% or our voting securities at that time
$50.0 million
2024

Affiliates purchased 4,135,650 shares of common stock in the February 2024 underwritten offering at the public offering price

Fairmount Funds Management LLC
a beneficial owner of more than 5% of our voting securities at that time
$15.0 million
2023

Affiliates purchased common stock and warrants, and pre-funded warrants and warrants, in the October 2023 underwritten offering

Perceptive Advisors, LLC
a beneficial owner of more than 5% of our voting securities at that time
$10.0 million
2023

Affiliates purchased common stock, warrants, pre-funded warrants and warrants in the October 2023 underwritten offering

FMR, LLC
a beneficial owner of more than 5% of our voting securities at that time
$5.6 million
2023

Affiliates purchased common stock and warrants in the October 2023 underwritten offering

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support